Garrido-Romero Manuel, Díez-Municio Marina, Moreno Francisco Javier
Instituto de Investigación en Ciencias de la Alimentación, CIAL (CSIC-UAM), Nicolás Cabrera 9, 28049 Madrid, Spain.
Pharmactive Biotech Products SLU, Faraday 7, 28049 Madrid, Spain.
Foods. 2025 Jul 8;14(14):2413. doi: 10.3390/foods14142413.
Recent advances highlight the crucial role of the gut microbiota in human health and disease, with dietary components emerging as powerful modulators of microbial communities. This review synthesizes current evidence on the effects of olive-derived bioactive compounds, including polyphenols (e.g., hydroxytyrosol, oleuropein or tyrosol), triterpenes and other phytochemicals on gut microbiota composition and function. These compounds have been shown to enhance beneficial bacterial populations such as and , reduce potentially pathogenic taxa, and promote the production of short-chain fatty acids and other health microbial metabolites, reinforcing intestinal barrier integrity. In vitro, in vivo, and clinical studies also reveal the potential of olive bioactives to ameliorate metabolic, inflammatory, and neurocognitive disorders through gut-microbiota-brain axis modulation. Despite promising results, key challenges remain, including interindividual microbiota variability, lack of standardized intervention protocols, and limited human clinical trials. Addressing these gaps through robust translational research could pave the way for microbiota-targeted, personalized nutritional strategies based on olive-derived compounds.
近期的进展凸显了肠道微生物群在人类健康与疾病中的关键作用,膳食成分已成为微生物群落的有力调节因子。本综述综合了当前有关源自橄榄的生物活性化合物(包括多酚类物质(如羟基酪醇、橄榄苦苷或酪醇)、三萜类化合物和其他植物化学物质)对肠道微生物群组成和功能影响的证据。这些化合物已被证明可增加有益细菌种群,如[具体细菌种群1]和[具体细菌种群2],减少潜在致病类群,并促进短链脂肪酸和其他有益健康的微生物代谢产物的产生,增强肠道屏障完整性。体外、体内和临床研究还揭示了橄榄生物活性物质通过调节肠道微生物群-脑轴来改善代谢、炎症和神经认知障碍的潜力。尽管取得了令人鼓舞的结果,但仍存在关键挑战,包括个体间微生物群的变异性、缺乏标准化的干预方案以及人类临床试验有限。通过强有力的转化研究解决这些差距,可为基于源自橄榄的化合物的微生物群靶向、个性化营养策略铺平道路。